Literature for peptidase C03.013: human rhinovirus 14-type 3C peptidase

Summary Alignment Tree Sequences Sequence features Distribution Literature Substrates

(Topics flags: S Structure, A Assay, I Inhibitor, P Specificity, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2024
  1. Morimoto,D. and Walinda,E.
    A fast and simple automated multi-step protein purification method for AKTA go systems
    Protein Expr Purif (2024) , 106560-106560. PubMed  Europe PubMed DOI
  2. 2022
  3. Dusekova,E., Berta,M., Sedlakova,D., Reha,D., Dzurillova,V., Shaposhnikova,A., Fadaei,F., Tomkova,M., Minofar,B. and Sedlak,E.
    Specific anion effect on properties of HRV 3C protease
    Biophys Chem (2022) 287, 106825-106825. PubMed  Europe PubMed DOI
  4. 2020
  5. Fan,X., Li,X., Zhou,Y., Mei,M., Liu,P., Zhao,J., Peng,W., Jiang,Z.B., Yang,S., Iverson,B.L., Zhang,G. and Yi,L.
    Quantitative analysis of the substrate specificity of human rhinovirus 3C protease and exploration of its substrate recognition mechanisms
    ACS Chem Biol (2020) 15, 63-73. PubMed  Europe PubMed DOI  P
  6. 2019
  7. Wagner,H.J. and Weber,W.
    Design of a human rhinovirus-14 3C protease-inducible caspase-3
    Molecules (2019) 24 PubMed  Europe PubMed DOI
  8. 2018
  9. Lotzerich,M., Roulin,P.S., Boucke,K., Witte,R., Georgiev,O. and Greber,U.F.
    Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death
    Cell Death Dis (2018) 9, 272-272. PubMed  Europe PubMed DOI
  10. 2017
  11. Antoniou,G., Papakyriacou,I. and Papaneophytou,C.
    Optimization of soluble expression and purification of recombinant human rhinovirus type-14 3C protease using statistically designed experiments: isolation and characterization of the enzyme
    Mol Biotechnol (2017) 59, 407-424. PubMed  Europe PubMed DOI  E
  12. 2016
  13. Ullah,R., Shah,M.A., Tufail,S., Ismat,F., Imran,M., Iqbal,M., Mirza,O. and Rhaman,M.
    Activity of the human rhinovirus 3C protease studied in various buffers, additives and detergents solutions for recombinant protein production
    PLoS ONE (2016) 11, e0153436-e0153436. PubMed  Europe PubMed DOI  E
  14. 2015
  15. Jensen,L.M., Walker,E.J., Jans,D.A. and Ghildyal,R.
    Proteases of human rhinovirus: role in infection
    Methods Mol Biol (2015) 1221, 129-141. PubMed  Europe PubMed DOI  V
  16. 2013
  17. Walker,E.J., Younessi,P., Fulcher,A.J., McCuaig,R., Thomas,B.J., Bardin,P.G., Jans,D.A. and Ghildyal,R.
    Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells
    PLoS ONE (2013) 8, e71316-e71316. PubMed  Europe PubMed DOI  PMC  EPMC
  18. 2012
  19. Schunemann,K., Connelly,S., Kowalczyk,R., Sperry,J., Wilson,I.A., Fraser,J.D. and Brimble,M.A.
    A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors
    Bioorg Med Chem Lett (2012) 22, 5018-5024. PubMed  Europe PubMed DOI  A
  20. Wishart,D.S.
    Picornain 3C (human rhinovirus)
    [ISSN:978-0-12-407743-0] (2012) 3, 2402-2406. DOI
  21. 2011
  22. Youell,J., Fordham,D. and Firman,K.
    Production and single-step purification of EGFP and a biotinylated version of the human rhinovirus 14 3C protease
    Protein Expr Purif (2011) 79, 258-262. PubMed  Europe PubMed DOI
  23. 2007
  24. Bjorndahl,T.C., Andrew,L.C., Semenchenko,V. and Wishart,D.S.
    NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (serotype 14): structural and dynamic comparison
    Biochemistry (2007) 46, 12945-12958. PubMed  Europe PubMed DOI  S  I
  25. 2004
  26. Wang,Q.M.
    Picornain 3C (human rhinovirus)
    [ISSN:0-12-079610-4] (2004) 2, 1358-1361.  V
  27. 2003
  28. Bjorndahl,T.C., Monzavi,H. and Wishart,D.S.
    Backbone 1H, 15N and 13C assignments for the human rhinovirus 3C protease (serotype 14)
    J Biomol NMR (2003) 26, 85-86. PubMed  Europe PubMed DOI
  29. 2002
  30. [YEAR:9-5-2002]Johnson,T.O., Hua,Y., Luu,H.T., Brown,E.L., Chan,F., Chu,S.S., Dragovich,P.S., Eastman,B.W., Ferre,R.A., Fuhrman,S.A., Hendrickson,T.F., Maldonado,F.C., Matthews,D.A., Meador,J.W., III, Patick,A.K., Reich,S.H., Skalitzky,D.J., Worland,S.T., Yang,M. and Zalman,L.S.
    Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease
    J Med Chem (9-5-2002) 45, 2016-2023. PubMed  Europe PubMed DOI  S  I
  31. 2001
  32. [YEAR:1-2-2001]Wang,Q.M. and Johnson,R.B.
    Activation of human rhinovirus-14 3C protease
    Virology (1-2-2001) 280, 80-86. PubMed  Europe PubMed DOI
  33. 1997
  34. Davis,G.J., Wang,Q.M., Cox,G.A., Johnson,R.B., Wakulchik,M., Dotson,C.A. and Villarreal,E.C.
    Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase
    Arch Biochem Biophys (1997) 346, 125-130. PubMed  Europe PubMed DOI
  35. Wang,Q.M., Johnson,R.B., Cox,G.A., Villarreal,E.C. and Loncharich,R.J.
    A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates
    Anal Biochem (1997) 252, 238-245. PubMed  Europe PubMed DOI  A
  36. Wang,Q.M., Johnson,R.B., Cohen,J.D., Voy,G.T., Richardson,J.M. and Jungheim,L.N.
    Development of a continuous fluorescence assay for rhinovirus 14 3C protease using synthetic peptides
    Antiviral Chem Chemother (1997) 8, 303-310.  A
  37. 1996
  38. Oren,D.A., Zhang,A., Nesvadba,H., Rosenwirth,B. and Arnold,E.
    Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14
    J Mol Biol (1996) 259, 120-134. PubMed  Europe PubMed DOI  S  I
  39. 1995
  40. Birch,G.M., Black,T., Malcolm,S.K., Lai,M.T., Zimmerman,R.E. and Jaskunas,S.R.
    Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli
    Protein Expr Purif (1995) 6, 609-618. PubMed  Europe PubMed DOI  E
  41. 1994
  42. Walker,P.A., Leong,L.E., Ng,P.W., Tan,S.H., Waller,S., Murphy,D. and Porter,A.G.
    Efficient and rapid affinity purification of proteins using recombinant fusion proteases
    Biotechnology (N Y) (1994) 12, 601-605. PubMed  Europe PubMed DOI
  43. 1993
  44. Leong,L.E., Walker,P.A. and Porter,A.G.
    Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5'-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities
    J Biol Chem (1993) 268, 25735-25739. PubMed  Europe PubMed
  45. 1990
  46. Cordingley,M.G., Callahan,P.L., Sardana,V.V., Garsky,V.M. and Colonno,R.J.
    Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro
    J Biol Chem (1990) 265, 9062-9065. PubMed  Europe PubMed  P
  47. 1989
  48. Cordingley,M.G., Register,R.B., Callahan,P.L., Garsky,V.M. and Colonno,R.J.
    Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli
    J Virol (1989) 63, 5037-5045. PubMed  Europe PubMed  PMC  EPMC  E
  49. Orr,D.C., Long,A.C., Kay,J., Dunn,B.M. and Cameron,J.M.
    Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli
    J Gen Virol (1989) 70, 2931-2942. PubMed  Europe PubMed
  50. 1988
  51. [YEAR:30-9-1988]Cheah,K.C., Sankar,S. and Porter,A.G.
    Expression and processing of human rhinovirus type 14 polypeptide precursors in Escherichia coli maxicells
    Gene (30-9-1988) 69, 265-274. PubMed  Europe PubMed